DROP program for patients starting oral cancer medicines
Part of Cancer clinical trials.
This trial studies whether a “DROP” support program helps ambulatory people with cancer manage drug-related problems when they start or change oral (by mouth) anticancer treatment. It may help reduce medication mistakes and complications by improving how you handle your regimen at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and have a cancer diagnosis
- Be starting or changing an oral anticancer medicine (by mouth)
- Plan to take the oral cancer medicine for about 6 months or more, and expect to live at least 6 months
- Be receiving the oral anticancer medicine through a community (town) pharmacy or a hospital pharmacy setup called “retrocession,” and be able to go home (not currently hospitalized for treatment)
- Take 5 or more medicines (including the oral cancer drug) or have a complicated treatment schedule (for example, 2 oral cancer drugs together or timed/sequenced doses)
- Be able to manage your medicines at home yourself (not only by a caregiver), and be able to read, write, and understand French; have no major memory or serious mental health problems in the investigator’s judgment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
This trial tests a program to help teenagers and young adults take their oral cancer medications as prescribed. It aims to make medication routines easier and improve adherence.
This study tests a program to help cancer patients who are starting their first oral chemo pill at home. It aims to improve understanding and safety of taking these medications.
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
This study tests whether a smartphone app (Caaring®) can help monitor cancer patients who take oral medications. If you are on an oral cancer treatment and comfortable using a smartphone, this trial may help you stay connected with your care team and manage side effects from home.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.